sglt2 inhibitors and glp-1 receptor agonists Diabetic Agents, From Metformin to GLP1 Agonists: JACC Focus Seminar Role of GLP-1 Agonists &

In general, GLP-1RAs present encouraging treatment alternatives for neurodegenerative diseases, providing novel pathways for managing these conditions and potential neuroprotective benefits

Liraglutide in apoE / mice reduced body weight as well as suppressed macrophage-driven atherosclerosis

[DOI] [PubMed] [Google Scholar] 146.Tsai MK, et al

coli by examing levels of intestinal NE

In patients without GI symptoms, but who have not held the medication as advised, the task force recommends proceeding with full stomach precautions with consideration for evaluating gastric volume by ultrasound to aid in decision-making

Additionally, the higher risk of surgical and long-term complications necessitates careful patient selection